Skip to main content

Author: Johnny Green

Indonesia’s Agriculture Minister: Cannabis Is Not Medicine

The cannabis plant is medicine. That is a fact that is often refuted by cannabis opponents despite the overwhelming evidence in support of the claim.

Cannabis has been used for medical purposes for centuries all over the world. Countless suffering patients all over the globe have used cannabis to successfully treat their conditions.

It is always worth noting that cannabis is a safer form of medicine compared to virtually all pharmaceutical drugs, and unlike those drugs, cannabis can be somewhat easily cultivated by the patients themselves.

Unfortunately, Indonesia’s Agriculture Minister feels that cannabis is not medicine, and is revoking a previous declaration that cannabis is a medicinal plant. Per The Jakarta Post:

The Agriculture Ministry will revise a 2020 ministerial decree that lists marijuana as a “medicinal plant” under the ministry’s supervision.

Signed on Feb. 3, the decree includes marijuana (Cannabis sativa) as one of 66 medicinal plants whose production is under the supervision of the ministry’s horticulture directorate general.

The decree went viral on Friday after the Nusantara Marijuana Network (LGN) posted a photo of the document on its Instagram account, @lgn_id.

This is an unfortunate and unfounded move by Indonesia’s Agriculture Minister. Cannabis is absolutely medicine, and the revoking of the previous decree is obviously motivated by political opinions and not by science and compassion.

Indonesia has historically been one of the harshest countries when it comes to cannabis policy so this move is not entirely unexpected, although it is still very disappointing to see.

Legal Cannabis Sales Outpace Unregulated Sales In Canada For The First Time

Legal adult-use cannabis sales started in Canada in 2018. Canada is only one of two countries where adult-use cannabis sales are legal, with the other one being Uruguay.

However, unlike Uruguay which limits sales to residents, Canada allows legal sales to all adults regardless of residence status. In so many ways Canada is the largest cannabis policy and industry experiment on earth.

Transitioning sales from unregulated sources to legal ones has been a turbulent process in Canada, which is not entirely unexpected. After all, Canada is the first nation to ever embark on such a massive cannabis industry undertaking, so setbacks were expected.

Since the launch of legal adult-use sales, Canada’s government has struggled to combat unregulated purchases, with the unregulated market receiving a larger share of sales compared to the regulated market. However, that changed recently with Canada recording its first quarter in which legal cannabis sales outpaced unregulated sales. Per Bloomberg:

Canadian household spending on legal cannabis in the second quarter of the year outpaced the illicit market for the first time, marking a significant milestone for the licensed pot industry.

Statistics Canada said Friday that Canadian household spending on recreational cannabis reached $648 million in the second quarter of 2020, an increase of 74 per cent from the same period last year. Meanwhile, spending on medical cannabis was flat at $155 million in the second quarter, StatsCan said.

Canadian household spending on illicit cannabis fell to a new low of $784 million in the second quarter, StatsCan added. Taken together, the legal cannabis market now accounts for 50.5 per cent of all pot-related spending in Canada.

This is a significant milestone for not only Canada but also for the rest of the world. All ‘cannabis policy eyes’ from around the world have been locked on Canada to see how things are unfolding.

The situation in Canada is far from perfect, however, the fact that the legal market is now seriously competing with the unregulated market is very significant. It’s a meaningful sign that legalization is working in Canada, and if Canada can do it presumably other nations around the globe can do it too.

U.S. Lawmakers Prepare For A Historic House Floor Cannabis Legalization Vote

September will reportedly see a historic cannabis legalization vote occur in the United States House of Representatives. Below is more information about it from our friends at NORML via a press release sent to the International Cannabis Business Conference:

House lawmakers are preparing for a September floor vote on legislation – The Marijuana Opportunity, Reinvestment, and Expungement Act a/k/a The MORE Act – to remove marijuana from the federal Controlled Substances Act. The forthcoming vote would mark the first time since the passage of the Controlled Substances Act of 1970, which placed cannabis in the same category as heroin as a Schedule I controlled substance, that a Congressional chamber has voted to remove marijuana from its prohibitive classification.

“Passage of The MORE Act is essential in order to truly right the wrongs of federal marijuana criminalization, and to once and for all allow the majority of states that have legalized cannabis for either medical or adult-use to embrace these policies free from the threat of undue federal prosecution or interference,” NORML Deputy Director Paul Armentano said.

Since the bill’s introduction last year, NORML has been a leader in the federal lobbying efforts in support of The MORE Act. To date, NORML members have sent over 100,000 messages to Congress in support of the Act’s passage.

Earlier this month, Democratic Presidential nominee Joe Biden chose California Senator Kamala Harris to be his running mate. Senator Harris is the lead sponsor of The MORE Act in the Senate. According to national polling data compiled by the Data for Progress think-tank, 62 percent of likely voters – including majorities of Democrats and Republicans – support passage of The MORE Act.

The House version of the Act, HR 3884, currently has over 85 cosponsors, including Assistant Speaker Ben Ray Lujan; Democratic Caucus Chairman Hakeem Jeffries and caucus-Vice Chair Katherine Clark; and Committee Chairs Maxine Waters, Jim McGovern, Raul Grijalva, and Nydia Velazquez; and Cannabis Caucus co-Chairs Earl Blumenauer and Barbara Lee.

Last November, members of the House Judiciary Committee advanced the House version of The MORE Act, marking the first time in history that federal lawmakers have moved forward legislation to remove (a/k/a deschedule) cannabis from the Controlled Substances Act (CSA). NORML believes that comprehensive federal marijuana policy reform is only possible via descheduling marijuana rather than by rescheduling it. Just as alcohol is not included in the CSA, thereby leaving states to be the primary regulators of their own alcohol policies, NORML maintains that cannabis should similarly be descheduled.

“Less than two years ago, we put out our blueprint outlining a path to cannabis legalization in the 116th Congress,” said Representative Earl Blumenauer, co-Chairman of the Congressional Cannabis Caucus. ”Now, after many months of hard work and collaboration, we finally have a chance to end the failed policy of prohibition that has resulted in a long and shameful period of selective enforcement against people of color, especially Black men. As people across the country protest racial injustices, there’s even greater urgency for Congress to seize this historic opportunity and finally align our cannabis laws with what the majority of Americans support, while ensuring restorative justice.”

The Act would also make several other important changes to federal policy. For example, it permits physicians affiliated with the Veterans Administration for the first time to make medical marijuana recommendations to qualifying veterans who reside in legal states, and it incentivizes states to move ahead with expungement policies that will end the stigma and lost opportunities suffered by those with past, low-level cannabis convictions. If approved, The MORE Act also allows the Small Business Administration to support entrepreneurs and businesses as they seek to gain a foothold in this emerging industry.

“A House floor vote will put our federal lawmakers on record,” NORML‘s Armentano said. ”We will know who stands with the majority of Americans in supporting an end to the failed federal policy of marijuana prohibition, and equally importantly, we will know in Congress wishes to continue to threaten the freedom and liberty of the millions of Americans who reside in states that have enacted common-sense alternatives to cannabis criminalization.”

###

NORML advocates for changes in public policy so that the responsible possession and use of marijuana by adults is no longer subject to criminal penalties. NORML further advocates for a regulated commercial cannabis market so that activities involving the for-profit production and retail sale of cannabis and cannabis products are safe, transparent, consumer-friendly, and are subject to state and/or local licensure. Finally, NORML advocates for additional changes in legal and regulatory policies so that those who use marijuana responsibly are no longer face either social stigma or workplace discrimination, and so that those with past criminal records for marijuana-related violations have the opportunity to have their records automatically expunged.

Find out more at norml.org and read our Fact Sheets on the most common misconceptions and myths regarding reform efforts around the country

Mexico’s President: Legalization Will Advance Through Congress

Mexico’s Congress is set to begin its session next month, and cannabis reform observers are eager to see what happens to cannabis legalization policy efforts that have been languishing for many months.

The Mexico Supreme Court ruled in 2018 that cannabis prohibition was unconstitutional and tasked Mexico’s lawmakers to draft, pass, and implement a cannabis regulation and legalization measure. The original deadline in which to do so was one year, however, 2019 came and went.

A new deadline was granted, and lawmakers then had until the end of April this year to comply with the Court’s ruling. Unfortunately, due to COVID that deadline came and went and a new deadline of December 15 is in place.

It is unclear what would happen if the new deadline was not complied with, yet cannabis reform supporters are hopeful that it will ultimately prove to be a moot point after Mexico’s President made comments recently that were very encouraging. Per Marijuana Moment:

The president of Mexico says that marijuana legalization will advance through Congress when it reconvenes next month—and he won’t stand in the way.

During a press conference on Wednesday, President Andrés Manuel López Obrador was asked about a recent meeting with a key senator who is championing the cannabis reform legislation and whether he’s supportive of the proposal.

He emphasized that “it must be taken into account that we are respectful of the division and balance between powers” when it comes to the executive and legislative branches of government, according to a translation, adding that the marijuana proposal has “been around for a long time.”

Mexico has a long history when it comes to the War on Drugs, and that includes cannabis. If/when legalization gets passed in Mexico it will be very interesting to see how things play out because of how complicated things are there.

It will also be interesting to see how the United States’ federal government reacts. After all, the United States will then be sandwiched in between two legal countries. Only time will tell.

Canadian Retailers Sold A Record Amount Of Adult-Use Cannabis In June

Canada is the undeniable international cannabis leader right now. The North American nation had a well-established cannabis industry prior to legalization, and when Canada legalized cannabis for adult-use it became only one of two countries to do so.

Uruguay is the only other country on the planet that has legalized cannabis for adult use, and unlike Canada, Uruguay does not allow non-residents to purchase cannabis.

Cannabis can be acquired through not-so-legal methods in every country on earth, but Canada is the only country where any legal-aged adult can make a legal purchase of cannabis flower and other cannabis products without any medical prescription or certification.

Canada’s adult-use law is not perfect, and the legal industry still struggles to keep up with the unregulated industry, however, that’s not to say that the legal industry isn’t getting stronger, as proven by June sales numbers from Statistics Canada.

Per sales data from Statistics Canadian, legal adult-use retailers sold over 201 million Canadian dollars worth of cannabis flower and other cannabis products in June. That is a nearly 8 percent increase over the previous monthly record which was set just in May 2020, the month prior.

Until another country legalized cannabis for adult use in a way that is as open as Canada, the country will presumably remain a top tourist destination for cannabis enthusiasts around the world, which should lead to increased sales numbers for the foreseeable future.

That is in addition to domestic customer demand continuing to shift from the unregulated market to the legal market, as well as international sales since Canada is a top global exporter of medical cannabis.

Check Out CB Club – Switzerland’s b2b Cannabis Meeting

Our friends at CannaTrade have an event coming up that you should absolutely check out. Below is a press release with more information!

Since 2016, when Switzerland legalised cannabis flowers with less than 1% THC as tobacco substitute, the cannabis branch is booming in Helvetia. The term CBD is on everyone’s lips, around 1000 companies were founded in the past time and Switzerland produces, exports and do researches according the legal action. In March 2020 the growing as well as the export of medical cannabis with over 1% THC was finally also accepted by the Swiss Parliament. The worldwide cannabis boom will certainly go on and Switzerland will play an important role.

The CannaTrade – International Cannabis Expo, taking place annually in springtime, has become an integral part of the international hemp world. For our business partners we additionally offer the new created CB Club – Switzerland’s b2b Cannabis Meeting:

In a small but fine scale with the «special something» producers, wholesale dealers, shop keepers, media and experts will meet informally at this Cannabis-Business-Network-Event. Get in contact with new and existing business partners, listen to interesting news on the current political situation, economy, legal condition, agronomy and medicine. By the way, the topics will be chosen by you!

Date – Wednesday 23rd of September 2020

Time -10.00 – 18.00 h

Place – Zurich, Swiss

Price- SFR 450 per Person

What to expect
Enjoy the whole day with culinary delights, special highlights and some surprises, all included in the price as well as your consumption.

The charming premises will offer enough space for undisturbed talks, entertaining points and also an integrated Fumoir (smoking compartment) for the smokers.

From time to time we will interrupt your conversations to contribute short reports on the items you have chosen by the registration. If you like to get detailed info on these subjects you can talk directly to the corresponding speakers afterwards. Factsheets on the various items are online available, so feel free to use both hands for other things.

For the purchase of a ticket you also have access to the b2b-online-area of the CB Club as well as of the CannaTrade. Meet your (new) customers and partners in a virtual way.

As the organisers of the CannaTrade, we certainly know who has to be a part of the event in any way.

Each registered company will be checked by us in advance.

Contact

Get in contact with us!

hello@cb-club.ch
0041 (0)31 398 02 35
www.cb-club.ch

Let’s grow your BUSINESS.

Maine Will Finally Launch Adult-Use Cannabis Sales This Fall

Maine was one of four states to legalize cannabis for adult-use in 2016 along with California, Nevada, and Massachusetts. However, unlike the other 3 legal U.S. states from the class of 2016, Maine has yet to launch legal adult-use cannabis sales.

Michigan and Illinois legalized adult-use cannabis after Maine, and yet both states have already launched legal adult-use cannabis sales. The delays in launching sales have cost the State of Maine a significant sum in lost cannabis tax and industry fee revenues. It has also prevented countless jobs from being created.

Fortunately for cannabis consumers in Maine, there appears to finally be a launch date for adult-use sales. Below is a press release about it via Maine’s Office of Marijuana Policy from late last week:

Today, the Office of Marijuana Policy, a part of the Maine Department of Administrative and Financial Services, unveiled plans for the issuance of Maine’s first active licenses for adult use marijuana establishments. The Office intends to issue the first active licenses to recreational cannabis businesses on Tuesday, September 8, 2020. Retail sales of adult use marijuana to consumers 21 years of age or older will be permitted starting on Friday, October 9, 2020.

The issuance of active licenses will continue the Office of Marijuana Policy’s structured rollout of Maine’s nascent adult use industry, which had been indefinitely postponed in April in response to the COVID-19 pandemic.

“The public’s health and safety are at the forefront of every decision we make at the Office of Marijuana Policy,” said OMP Director Erik Gundersen. “While we were poised to launch this new industry earlier this year, we were unwilling to sacrifice the high standards we have set for this program by launching during an emerging public health pandemic and in the absence of a testing facility. With the support of the public health community, municipalities across the state, and the industry we regulate, we have used the last few months to ensure this new industry is introduced to Maine consumers in a manner that is as responsible as possible.”

Active licensure is the culmination of a three-step application process which also includes conditional licensure and local authorization, respectively. An active license is required for adult use establishments to come into possession, process and sell adult use marijuana, including initiating plant transfers from Maine’s existing medical marijuana program.

It is expected adult use licensees will utilize the time between active licensure and Maine’s retail sales launch date to harvest and process marijuana, ensure those products satisfy the mandatory testing requirements, and move product through the supply chain to stock retail store shelves. Additionally, businesses which will conduct retail sales will prepare to implement and support social distancing and other public health guidance at a time when public interest may attract a significant consumer presence to their retail locations.

“Today’s announcement is a major milestone in honoring the will of Maine voters and a significant step toward launching a new industry in the state,” added Gundersen. “Many of the business owners we have spoken with during the application process are ready and eager to commence operations.”

The application process required by the adult use law requires state regulators to review application materials for form and substance, with an eye toward details such as ensuring that all applicants have completed their required state and federal criminal history record checks; that the establishment’s operation, facility, and security plans satisfy the requirements of both the Marijuana Legalization Act and the adult use program rule; and that the designated host municipality has provided the applicant with authorization to conduct business in their community.

OMP expects to issue licenses in each of the four categories of adult use establishments: cultivation, products manufacturing, retail sale, and testing. Information on the specific number of licenses issued and the identities of active licensees will be made available on Tuesday, September 8, 2020.

The Mills Administration created OMP within DAFS in February 2019. The Office is responsible for the oversight of all aspects of legalized marijuana, including Maine’s existing Medical Use of Marijuana Program.

New Zealand Cannabis Legalization Vote Moved To October

New Zealand is the only country voting on a national cannabis legalization measure in 2020. As of right now, adult-use cannabis is only legal in two countries – Uruguay and Canada.

Two other countries, Mexico and Italy, are in the process of implementing previous court rulings which determined that cannabis prohibition is unconstitutional in those nations.

A handful of other countries are exploring pilot programs that would legalize cannabis for adult-use in limited instances.

The cannabis legalization measure in New Zealand is part of the overall General Election, which was originally scheduled to take place on September 19, 2020. However, a recent COVID-19 outbreak has resulted in the election, and with it the vote on legalization, being moved to October. Per Stuff:

Prime Minister Jacinda Ardern has delayed the 2020 election by a month, with a new polling day set for October 17.

Ardern has been under increasing pressure to delay the election, previously set for September 19, after Auckland was placed in a two-week lockdown due to an outbreak of Covid-19 in the community, leading to a halt in most political campaigning.

Parliament will now dissolve on September 6, with early voting starting on October 3 and overseas voting starting on September 30. The two referendums scheduled to coincide with the election will also be moved.

Polling for the cannabis legalization measure has been all over the board, with some polls showing it losing and others showing that it will win once it is voted on. Ultimately, only time will tell.

The delayed vote could prove to be a blessing for cannabis advocates because it gives them more time to convince voters that cannabis prohibition is a failure and that it’s time for a more sensible approach.

To be fair, it also provides more time for opponents to pursue their goal of convincing voters in New Zealand that prohibition is working.

Most Americans In Legal States Express “Positive Perceptions” Of The Cannabis Marketplace Per Study

Below is a press release that we received from our friends at NORML:

Adults residing in states where retail marijuana sales are legally regulated tend to hold a positive impression of the marketplace, according to data published in the journal Addictive Behaviors.

Commenting on the study’s findings, NORML’s Deputy Director Paul Armentano said: “This data once again affirms that most voters do not experience ‘buyer’s remorse’ following marijuana legalization. In the minds of most Americans, these laws are operating as voters intended and in a manner that is consistent with their expectations.”

Investigators affiliated with the University of Waterloo, School of Public Health in Canada surveyed 5,530 respondents residing in Alaska, California, Colorado, Nevada, Oregon, and Washington.

Authors reported: “The current findings suggest generally positive perceptions of the legal cannabis market. Most respondents, including frequent cannabis consumers, perceived legal cannabis to be of equal or greater quality and convenience, and as safer to buy and use than cannabis from illegal sources.”

NORML’s Armentano further acknowledges that no state that has legalized the use of cannabis for either medical or adult-use purposes has ever repealed their law.

Although some respondents in the study expressed concerns that legally sold cannabis products tend to be more expensive than those available in the illicit market, most also acknowledged that prices typically fall over time as the market matures. Overall, respondents were likely to think most favorably about the marketplaces in the jurisdictions where cannabis had been legal the longest.

The findings are consistent with prior studies finding that most Americans believe that the enactment of marijuana legalization policies has been successful.

An abstract of the study, “Consumer perceptions of ‘legal’ and ‘illegal’ cannabis in US states with legal cannabis sales,” appears online here.

###

NORML advocates for changes in public policy so that the responsible possession and use of marijuana by adults is no longer subject to criminal penalties. NORML further advocates for a regulated commercial cannabis market so that activities involving the for-profit production and retail sale of cannabis and cannabis products are safe, transparent, consumer-friendly, and are subject to state and/or local licensure. Finally, NORML advocates for additional changes in legal and regulatory policies so that those who use marijuana responsibly are no longer face either social stigma or workplace discrimination, and so that those with past criminal records for marijuana-related violations have the opportunity to have their records automatically expunged.

Find out more at norml.org and read our factsheets on the most common misconceptions and myths regarding reform efforts around the country at norml.org/marijuana/fact-sheets